Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases

References

• Roden MM, Zaoutis TE, Buchanan WL, . Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41:634–653.
   PubMed Web of Science ®Google Scholar
• Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am. 2002; 16:895–914.vi
   PubMed Web of Science ®Google Scholar
• Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis. 2004; 17:517–525.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Das A, Mandal J, . The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006; 44:335–342.
   PubMed Web of Science ®Google Scholar
• Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006; 25:215–229.
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis. 2004; 39:588–590.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DR Wessel VC, Bodey GR Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis. 2000; 30:851–856.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DR Lionakis MS, Lewis RE, . Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. Infect Dis. 2005; 191:1350–1360.
   Web of Science ®Google Scholar
• Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004; 350:950–952.
   PubMed Web of Science ®Google Scholar
• Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, . Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis. 2004; 39:584–587.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J Jr. , Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management.
   Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002; 34:909–917.
   PubMed Web of Science ®Google Scholar
• Sims CR, Ostrosky-Zeichner L. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res. 2007; 38:90–93.
   PubMed Web of Science ®Google Scholar
• Tang D, Wang W. Successful cure of an extensive burn injury complicated with Mucor wound sepsis. Burns. 1998; 24:72–73.
   PubMed Web of Science ®Google Scholar
• Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis. 1994; 19:1133–1137.
   PubMed Web of Science ®Google Scholar
• Nagy-Agren SE, Chu R Smith GJ, Waskin HA, Altice FL. Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retroviral. 1995; 10:441–149.
   PubMedGoogle Scholar
• Almyroudis NG, Sutton DA, Linden P, . Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006; 6:2365–2374.
   PubMed Web of Science ®Google Scholar
• Larkin J, Montero J. Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med. 2003; 20:201–206.
   Web of Science ®Google Scholar
• Perfect JR. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis. 2005; 40Suppl. 6:S401–408.
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Letscher-Bru V, Bowden RA, . Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis. 2001; 20:460–466.
   PubMed Web of Science ®Google Scholar
• Linden P Williams P Chan KM. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Clin Transplant. 2000; 144 Pt 1:329–339.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Hiemenz JW, Seibel NL, . Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998; 26:1383–1396.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008; 46:1813–1821.
   PubMed Web of Science ®Google Scholar
• Bates DW, Su L, Yu DT, . Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001; 32:686–693.
   PubMed Web of Science ®Google Scholar
• Patterson RM, Ackerman GL. Renal tubular acidosis due to amphotericin B nephrotoxicity. Arch Intern Med. 1971; 127:241–244.
   PubMedGoogle Scholar
• Walsh TJ, Finberg RW, Arndt C, . Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999; 340:764–771.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Goodman JL, Pappas P, . Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother. 2001; 45:3487–3496.
   PubMed Web of Science ®Google Scholar
• Comely OA, Maertens J, Bresnik M, and AmBiLoad Trial Study Group. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007; 44:1289–1297.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009; 48:1743–1751.
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J, Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005; 18:556–569.
   PubMed Web of Science ®Google Scholar
• Reed C, Bryant R, Ibrahim AS, . Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008; 47:364–371.
   PubMed Web of Science ®Google Scholar
• Groll AH, Lyman CA, Petraitis V, . Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations. Antimicrob Agents Chemother. 2006; 50:3418–3423.
   PubMed Web of Science ®Google Scholar
• Gil-Lamaignere C, Simitsopoulou M, Roilides E, . Interferon-gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis. 2005; 191:1180–1187.
   PubMed Web of Science ®Google Scholar
• Rodriguez MM, Calvo E, Marine M, . Efficacy of liposomal amphotericin B combined with interferon-gamma or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice. Antimicrob Agents Chemothe. 2009; 53:3569–3571.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Kontoyiannis DP. What is the role of combination therapy in management of zygomycosis? Invited Editorial. Clin Infect Dis. 2008; 47:372–374.
   PubMed Web of Science ®Google Scholar
• Neofytos D, Horn D, Anaissie E, . Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009; 48:265–273.
   PubMed Web of Science ®Google Scholar
• Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases?. Leuk Lymphoma. 2004; 45:1351–1360.
   PubMed Web of Science ®Google Scholar